Fundz

Acurion reported raising $4.3 Million in an initial SEC Form D filing, from an offering of $4.5 Million

PRIVATEApr 03, 2026$4.3M of $4.5M raised

Amount Raised

$4.3 Million

$4.3 Million per company press release (Apr 3, 2026)

Round Type

Seed

San DiegoBiotechnologyHealth CareArtificial IntelligenceTherapeutics

Investors

Mesa Verde Venture PartnersThe National Foundation For Cancer ResearchAsian Fund For Cancer ResearchBootstrap VenturesTK & Partners

Description

Acurion, a San Diego-based precision oncology technology company, closed its $4.3M seed financing round. The round was led by TK & Partners, with investments from several prominent venture partners and institutional investors. The funding will aid in the clinical validation and commercialization of their OncoGaze™ platform. Acurion aims to enhance precision medicine through its innovative AI-powered image analysis tools.

Quick answer

Acurion raised $4.3 Million in a Seed round, dated March 17, 2026. Investors: Mesa Verde Venture Partners, The National Foundation For Cancer Research, Asian Fund For Cancer Research, Bootstrap Ventures and TK & Partners. Acurion is based in San Diego, California, United States.

How much did Acurion raise?
Acurion raised $4.3 Million in a Seed round on March 17, 2026.
Who invested in Acurion?
Mesa Verde Venture Partners, The National Foundation For Cancer Research, Asian Fund For Cancer Research, Bootstrap Ventures and TK & Partners are named as investors in this round.
What does Acurion do?
Acurion, formerly known as io9, is committed to making precision medicine a reality for cancer patients.
Where is Acurion based and how big is it?
Acurion is based in San Diego, California, United States.
Who are the decision-makers at Acurion?
Fundz holds 2 contacts at Acurion, including the CEO. Names and contact details are shown to Fundz members.

Source: Fundz verified event record.

Who else raised in Therapeutics and Biotechnology around the same time

Companies in the same sectors as Acurion that raised within 45 days of this round, from Fundz verified event records.

  • Change Agents Corporation. raised $207K (Debt Financing) on February 25, 2026.
  • mbiomics raised $35M (Series A) on April 29, 2026.
  • Dehaze GmbH raised $3.7M (Seed) on April 28, 2026.
  • Coultreon Biopharma raised $125M (Series A) on April 28, 2026.
  • dehaze raised $3.7M (Seed) on April 28, 2026.
  • SquareMind raised $18M (Series A) on April 27, 2026.

Who to call at Acurion, and when

A new round usually means Acurion is about to hire and buy. The teams that reach out first get the meeting.

  • An alert the day Acurion raises, hires an executive or expands, scored against what you sell
  • The decision-makers there, with verified emails
  • Who you already know at Acurion, from your own LinkedIn network

Works inside ChatGPT and Claude. Ask who to call at Acurion. With Fundz connected, it knows.

Watch Fundz in
See plan options
Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce 4.8/5 on G2

Company Information

Company

Acurion

Location

San Diego, California, United States

About

Acurion, formerly known as io9, is committed to making precision medicine a reality for cancer patients. The company offers innovative AI technology for rapid identification of genomic biomarkers to enhance treatment selection. Acurion’s approach aims to reduce the time from diagnosis to treatment significantly. It is focused on transforming the field of oncology through its groundbreaking platform, OncoGaze.

AI made execution free. Knowing first is the whole game now.

Fundz sees it the moment Acurion raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.

Related People

2 contacts
Verified contactsRick F., CEO hidden hiddenSee plans and pricing
Predictive Intelligence
Strategic

ML-powered predictions for Acurion's next move

See what Strategic adds

Acurion raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.

145 of these a day, filtered to the companies you pick, with the decision-maker attached.

5 screens from a live account. No signup.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 281,000+ organizations. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.